Align Technology, Inc.

ALGN • Medical - Devices

$158.63

— 0.00 (0.00%)

ResultadosÚltimo reporte: 30 jun 2026

PERFIL EQUILIBRADONeutralConfianza: 70%

Perfil cuantitativo — no constituye una recomendación de inversión.

Perfil cuantitativo — no constituye una recomendación de inversión.Metodología

Tesis del análisis: Perfil mixto. La empresa no es necesariamente mala, pero la valoración, el crecimiento o el balance todavía no justifican una señal más fuerte.

Capitalización

$11.36B

Crecimiento

27.6%

Flujo de caja

5/5

Tendencia

Stable

Evidencia

Márgenes estables o en mejora · 10.2%Flujo de caja libre positivo · 6.77Flujo de caja libre consistente · 5/5Nivel de deuda manejable · 0.03Liquidez saludable · 1.36

Datos financieros hasta: 30 jun 2026, 12:00 a.m. UTCÚltima actualización de earnings: 30 jun 2026, 12:00 a.m. UTCÚltima actualización del perfil: 7 ago 2026, 12:30 p.m. UTC

Resumen de la compañía

Valoración, calidad, fortaleza financiera, momentum y datos de analistas.

Price$158.64

Change0.00%

Shares Out71.63M

Market Cap$11.36B

Enterprise Value$10.35B

52W Range122.00 - 200.44

Beta1.67

P/E27.47

P/S2.74

P/B2.68

P/FCF14.16

EV/Sales2.50

Price$158.64

Change0.00%

Shares Out71.63M

Market Cap$11.36B

Enterprise Value$10.35B

52W Range122.00 - 200.44

Beta1.67

P/E27.47

P/S2.74

P/B2.68

P/FCF14.16

EV/Sales2.50

EV/EBITDA14.88

EV/FCF12.89

Earnings Yield3.64%

FCF Yield7.06%

Dividend Yield0.00%

Gross Margin68.33%

Oper. Margin15.27%

Profit Margin10.17%

Debt/Eq0.03

Current Ratio1.36

Quick Ratio1.24

Revenue 5Y27.65%

Target$205.25

Target Upside29.39%

Target Median$199.00

Target Range188.00 - 235.00

Volume629.74K

Avg Volume1.02M

EPS Surprise0.32

ADN de inversión

Qué tan fuerte luce esta compañía para inversionistas de largo plazo

de 100

Calidad del negocio

Márgenes, ventaja competitiva, retornos

60/100

Fortaleza financiera

Deuda, caja, estabilidad

67/100

Potencial de crecimiento

Ingresos y expansión

33/100

Atractivo del precio

Barata o cara hoy

68/100

Por qué este puntaje▼

Márgenes estables o en mejora · 10.2%Flujo de caja libre positivo · 6.77Flujo de caja libre consistente · 5/5Nivel de deuda manejable · 0.03Liquidez saludable · 1.36Tendencia de crecimiento negativa

Analyst view

Analyst sentiment and price target

ALGN

Analyst sentiment

Based on 33 analyst votes · 2026-09-05

83/100

Bullish

Hold

Bearish

Precio objetivo

2026-08-07

Bajo

$188.00

Promedio

$203.50

Mediana

$200.00

Alto

$235.00

Resumen de la compañía

IPO: 1/30/2001

Industria: Medical - Devices

P/B i: 2.68

Deuda / Patrimonio i: 0.03

Margen operativo: 15.27%

Margen neto: 10.17%

ROE i: -

ROIC: -

Salud financiera

Puntaje13 / 20

Deuda / Patrimonio: 0.03

Ratio corriente: 1.36

Ratio rápido: 1.24

Estado: Good

Transacciones internas

Actividad reciente de ejecutivos e insiders

MORROW GEORGE J

Transacción: 05/20/2026

VENTA

Cambio

-1,745

Precio

Not reported

Presentación

05/22/2026

Tipo

VENTA

MORROW GEORGE J

Transacción: 05/20/2026

COMPRA

Cambio

+1,745

Precio

Not reported

Presentación

05/22/2026

Tipo

COMPRA

Conroy Kevin T

Transacción: 05/20/2026

VENTA

Cambio

-1,745

Precio

Not reported

Presentación

05/22/2026

Tipo

VENTA

Insider	Tipo	Cambio	Precio	Transacción	Presentación
MORROW GEORGE J	VENTA	-1,745	Not reported	05/20/2026	05/22/2026
MORROW GEORGE J	COMPRA	+1,745	Not reported	05/20/2026	05/22/2026
Conroy Kevin T	VENTA	-1,745	Not reported	05/20/2026	05/22/2026
Conroy Kevin T	COMPRA	+1,745	Not reported	05/20/2026	05/22/2026
LACOB JOSEPH	VENTA	-1,745	Not reported	05/20/2026	05/22/2026
LACOB JOSEPH	COMPRA	+1,745	Not reported	05/20/2026	05/22/2026
Dallas Kevin J	VENTA	-1,745	Not reported	05/20/2026	05/22/2026
Dallas Kevin J	COMPRA	+1,745	Not reported	05/20/2026	05/22/2026
LARKIN C RAYMOND JR	VENTA	-2,326	Not reported	05/20/2026	05/22/2026
LARKIN C RAYMOND JR	COMPRA	+2,326	Not reported	05/20/2026	05/22/2026
Myong Anne	VENTA	-1,745	Not reported	05/20/2026	05/22/2026
Myong Anne	COMPRA	+1,745	Not reported	05/20/2026	05/22/2026
Poul Mojdeh	VENTA	-1,745	Not reported	05/20/2026	05/22/2026
Poul Mojdeh	COMPRA	+1,745	Not reported	05/20/2026	05/22/2026
Saia Andrea Lynn	VENTA	-1,745	Not reported	05/20/2026	05/22/2026
Saia Andrea Lynn	COMPRA	+1,745	Not reported	05/20/2026	05/22/2026
SIEGEL SUSAN E	VENTA	-1,745	Not reported	05/20/2026	05/22/2026
SIEGEL SUSAN E	COMPRA	+1,745	Not reported	05/20/2026	05/22/2026
Vitalone Britt J.	COMPRA	+1,443	Not reported	05/20/2026	05/22/2026
Vitalone Britt J.	VENTA	-1,443	Not reported	05/20/2026	05/22/2026

Sobre la compañía

Align Technology, Inc.

Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.

Fuente - Link

Competidores

BIO BMRN ENSG EXEL GMED HIMS PEN QGEN RVTY

Tamaño = capitalización · color = línea del gráfico

Rendimiento de peers · 1A

Top performers + empresa seleccionada

Ultimas Noticias

Quentin Blackford to Join Align Technology Board of Directors

TEMPE, Ariz. & SAN JOSE, Calif.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that its Board of Directors has appointed Quentin Blackford, President and Chief Executive Officer of iRhythm Technologies, as a director effective immediat.

Business Wire

26,510 Shares in Align Technology, Inc. $ALGN Acquired by Canada Pension Plan Investment Board

Canada Pension Plan Investment Board bought a new position in Align Technology, Inc. (NASDAQ: ALGN) in the quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 26,510 shares of the medical equipment provider's stock, valued at approximately $4,471,000. Other institutional

Defense World

Why Is Align Technology (ALGN) Down 8.4% Since Last Earnings Report?

Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research

Align Technology Inc (ALGN) Stock Down 5.6% -- Now Undervalued? GF Score: 89/100

On August 17, 2026, Align Technology Inc (ALGN) shares fell 5.6%, bringing the current price to $171.16. The stock has experienced a 52-week range of $122.00 to

GuruFocus

How the U.K. VAT Ruling Could Reshape Align's 2026 Earnings Outlook

Align's $37.5M U.K. VAT liability, new 20% VAT charges and pending appeal add fresh earnings uncertainty amid currency and mix pressures.

Zacks Investment Research

Sorpresas de ganancias

Período	Estimado	Real	Sorpresa
2026-04-29	2.26	2.58	0.32
2026-02-04	2.99	3.29	0.3
2025-10-29	2.4	2.61	0.21
2025-07-30	2.57	2.49	-0.08
2025-04-30	1.99	2.13	0.14
2025-02-05	2.43	2.44	0.01
2024-10-23	2.31	2.35	0.04
2024-07-24	2.34	2.41	0.07
2024-04-24	1.97	2.14	0.17
2024-01-31	2.18	2.42	0.24
2023-10-25	2.26	2.14	-0.12
2023-07-26	2.02	2.22	0.2